Evidence map›Paper›PMID 42741106›Full record

ArticleFrontiers in medicine2026

Urine inflammatory protein levels decrease following kidney transplantation.

Elizabeth Spiwak, Corina Nailescu, David S Hains, Marah Kolner, Samual Arregui, Andrew L Schwaderer

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elizabeth SpiwakDivision of Pediatric Nephrology, Peyton Manning Children's Hospital, Indiana University, Indianapolis, IN, United States.
Corina NailescuDivision of Nephrology, Department of Pediatrics, Indiana University, Indianapolis, IN, United States.
David S HainsDivision of Nephrology, Department of Pediatrics, Indiana University, Indianapolis, IN, United States.
Marah KolnerBioengineering Summer Internship Program, Indiana University, Indianapolis, IN, United States.
Samual ArreguiDivision of Nephrology, Department of Pediatrics, Indiana University, Indianapolis, IN, United States.
Andrew L SchwadererDivision of Nephrology, Department of Pediatrics, Indiana University, Indianapolis, IN, United States.

Funding

Indiana University Kidney Training Program (IU-KTP)T32DK120524 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M · 2019 to 2023
$1.3M
NIDDK NIH HHS T32 DK120524
6 · The paper itself

Abstract

Background: Kidney transplant recipients are subjected to several types of immunosuppressants in order to prevent rejection of the graft. Over-immunosuppression increases the risk of infectious complications and thesepatients require a delicate balance. Inflammatory profiles from the urine can help identify which biomarkersmay guide clinicians in balancing over vs. under-immunosuppression. Methods: Urine samples were obtained from 10 complete kidney donor-recipient pairs at a pre-operative visit ~1 weekprior to or at time of transplant and then for the recipients, ~3 months following transplantation. The urine samples were analyzed using inflammatory urine biomarker profiles (Mesoscale Discovery). Urine levels were then normalized to urine creatinine values. Differences were noted between groups using the mixed-measures ANOVA, corrected for multiple comparisons with the Tukey test to get adjusted Results: Urine levels of TARC protein, also known as CCL17 and Tumor necrosis factor alpha (TNF- Conclusion: The urine inflammatory profile evolves over the transplant course between donors, pre-transplantrecipients and transplant recipients. Although the transplant itself is typically accepted as a pro-inflammatory event, levels of biomarks in the urine tend to decrease post-transplant. Immunosuppression regimens may influence inflammatory profiles and warrant further investigation.

Indexed as

antimicrobial peptide (AMP)biomarkerchronic kidney diseaseimmunosuppressioninflammation

Identifiers

PMID42741106
PMCPMC13572213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.